Final Programme Eurobiofilms 2017 Fifth European Congress ... · September 19-22, Amsterdam, The...

Final Programme

Eurobiofilms 2017

Fifth European Congress on Microbial

Biofilms

Amsterdam, September 19-22, 2017

Eurobiofilms 2017

The Eurobiofilms2017 meeting has been financially supported by:

Table of Contents

Welcome Message .................................................................................................... 1

Programme Overview ................................................................................................ 2

Scientific Programme Oral Sessions ........................................................................ 10

General Information ................................................................................................ 25

Information for Presenters ...................................................................................... 27

Poster Line-up .......................................................................................................... 30

September 19-22, Amsterdam, The Netherlands - 1 -

Dear delegates,

On behalf of the ESCMID Study Group on Biofilms (ESGB) it is our great pleasure to

welcome you to Amsterdam for Eurobiofilms 2017. This European congress on

microbial biofilms is organized for the 5th time and is attracting a large international

audience.

With over 250 participants from 30 different countries it is clear that this conference

contributes to connecting people in the biofilm field. This connection is

interdisciplinary as becomes clear by the upcoming special virtual joint issue of FEMS

Pathogens and Disease and FEMS Microbiology Ecology, illustrating that there are no

fundamental distinctions between medical and ecological biofilms.

Besides the academic interest, industry has also developed a keen interest in biofilm

research. We are therefore very happy to see that 9 companies have decided to

support and participate in our meeting, illustrating the social importance of this

meeting.

In addition to the exchange of scientific information and insights, the main purpose

of this meeting is to (re-)connect and advance research in the field of biofilms. The

program is setup to facilitate contact time and the venue offers a range of

possibilities to meet and discuss in larger and smaller groups.

We think that this meeting offers you an interesting program, and we hope that you

will enjoy this meeting in both a scientific and social perspective.

Bastiaan Krom,

Rob Exterkate

Michel Hoogenkamp

Congress Secretariat:

MCI Denmark – [email protected]

- 2 - Eurobiofilms 2017

Programme Overview Tuesday September 19, 2017

Venue : Academic Centre for Dentistry Amsterdam

08:00 - 11:00 Registration desk is open at ACTA

09:00 - 10:30

Combined workshops

Room 0Z-01

10:30 - 11:00 Coffee Break

11:00 - 13:00 Combined workshops

Room 0Z-01

13:00 - 13:45 Lunch Break

13:45 - 17:00 Workshop: In-vitro biofilm modelling

Rooms 13N-20 / 11N-62

Workshop: Experimental biofilm infection in Animals

Room 0Z-01

16:00 - 19:00 Registration desk is open at ACTA

17:30 - 17:45 Welcome to Eurobiofilms 2017

Lecture Hall

17:45 - 18:30 Opening Lecture Phil Marsh

Lecture Hall

18:30 - 20:30 Opening Reception (only for registered attendees)


Programme Overview Wednesday September 20, 2017

Venue : De Meervaart Theatre

08:00 - 10:00 Registration desk is open at De Meervaart Poster Set-up

08:45 - 09:00 Announcements Eurobiofilms 2017

Red Room

09:00 - 09:45 Key Note Lecture - Kim Lewis

Red Room


10:15 - 12:05 Session 1 Oral Biofilms in Health and Disease

Red Room

Session 2 Biofilm Based Medical Device Related Infections

Blue Room

12:05 - 13:00 Lunch Break

13:00 - 14:50 Session 3 Treatment of Biofilm Infections and Development of Biofilm Resistance

Red Room

Session 4 Environmental Biofilms, Consequences for Health and Disease

Blue Room


15:15 - 16:25 Session 5 Biofilms Systems Biology

Red Room

Session 6 Biofilm Matrix

Blue Room

16:25 - 17:05 Poster Session A

Lobby and Foyer 1st

Floor

17:05 – 17:45 Poster Session B (with Complimentary drinks)

Lobby and Foyer 1st

Floor


Programme Overview Thursday September 21, 2017


08:00- Registration desk is open

09:00-09:45 Key Note Lecture - Thomas Wood

Red Room

09:45-10:15 Coffee Break

10:15-12:05 Session 7 Host Responses to Biofilms and Potential Vaccination Targets

Red Room

Session 8 Evolution and Adaptation in Biofilms

Blue Room

12:05-13:00 Lunch Break

13:00-14:50 Session 9 Mixed Species Biofilms

Red Room

Session 10 Microenvironment and Physiology of Infectious Biofilms

Blue Room


15:20-16:00 Poster Session C

Lobby and Foyer 1st

Floor

16:00-16:40 Poster Session D (with complimentary drinks)

Lobby and Foyer 1st

Floor


Programme Overview Friday September 22, 2017


08:00- Registration desk is open

09:00 – 10:50 Session 11 Mechanics and Physics in and of Biofilms

Red Room

Session 12 Social Interactions in Mixed Species Biofilms

Blue Room

10:50 – 11:20 Coffee Break

11:20 – 13:00 Session 13 Remaining Fundamental Questions and Standardization in Biofilm research

Red Room

12:40-13:00 Poster awards and Closing Ceremony

Red Room



Scientific Programme

Tuesday September 19 – Venue: ACTA

08:00-11:00 Registration desk is open at the ACTA building

16:00-19:00 Registration desk is open at the ACTA building

Lecture hall

17:30-17:45

Welcome to Eurobiofilms 2017

Local Organizing committee, ESGB board members

17:45-18:30

Opening Lecture:

K-01 : Dental biofilms – Something to Get Your Teeth Stuck Into!

Phil Marsh, Public Health Service England, Salisbury, UK

18:30-20:30 Opening Reception (only for registered attendees)

Wednesday September 20 – Venue: de Meervaart Theatre

08:00-08:45 Registration and Poster-Set Up

08:00-10:00 Registration desk is open

08:45-9:00

Red Room

Announcements Eurobiofilms 2017

Local Organizing committee

09:00-9:45

Red Room

Key Note Lecture:

K-02 : Biofilm Tolerance to Antibiotics

Kim Lewis, Northeastern University, Boston , USA



Notes :

...............................................................................................................................

...............................................................................................................................

...............................................................................................................................

...............................................................................................................................

...............................................................................................................................

...............................................................................................................................

...............................................................................................................................

...............................................................................................................................

...............................................................................................................................

...............................................................................................................................

...............................................................................................................................

...............................................................................................................................

...............................................................................................................................

...............................................................................................................................

...............................................................................................................................

...............................................................................................................................

...............................................................................................................................

...............................................................................................................................

...............................................................................................................................



Session 1

Red Room

Oral Biofilms in Health and Disease

Sponsored by ACEA Biosciences

Chairs: Egija Zaura (The Netherlands), Alex Mira (Spain)

10:15-10:40

S-01 : Oral Biofilm in an Ecological Perspective

Egija Zaura (The Netherlands)

10:40-10:55

S-02 : In Vitro Dysbiotic Oral Biofilms Deregulate the Host

Immune Response

Esteban Rodriguez Herrero (Belgium)

10:55-11:10

S-03 : Control of Oral Biofilms Using Natural Microbial Enzymes

Nadia Rostami (United Kingdom)

11:10-11:25

S-04 : Biofilm Formation of Oral Bacteria by Membrane Vesicles

from S. mutans

Hidenobu Senpuku (Japan)

11:25-11:40

S-05 : Oral Biofilms as a Source of Probiotics

Tomaz Rijavec (Slovenia)

11:40-12:05

S-06 : Measuring Oral Biofilms Growth in Real Time: Insights and

Applications

Alex Mira, (Spain)




Session 2

Blue Room

Biofilm Based Medical Device Related Infections

Chairs: Trine Rolighed Thomsen (Denmark), Bas Zaat, (The

Netherlands)

10:15-10:40

S-07 : Diagnosis And Understanding of Implant Related Biofilm

Infections

Trine Rolighed Thomsen, (Denmark)

10:40-10:55

S-08 : Development of an Ex Vivo Joint Model to Study Biofilm

Infections

Helen Brown (United Kingdom)

10:55-11:10

S-09 : Microbial Communities Associated with Supposedly Non-

Infected Implants

Tim Jakobsen (Denmark)

11:10-11:25

S-10 : Integrative Ureteral Stent Biofilm Analysis: Towards a

Biofilm Model

Matthias Buhmann (Switzerland)

11:25-11:40

S-11: Embp Mediates S. epidermidis Adherence to Immobilized

Fibronectin

Henning Büttner (Germany)

11:40-12:05

S-12 : Novel Antibiofilm Approaches from BALI and IBIZA

Bas Zaat (The Netherlands)


Notes

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................



Session 3

Red Room

Treatment of Biofilm Infections and Development of Biofilm

Resistance

Chairs: Claudia Vuotto (Italy), Jeremy Webb, (United Kingdom)

13:00-13:25 S-13 : Drug Resistance in Biofilm and Possible Strategies to

Overcome it

Claudia Vuotto (Italy)

13:25-13:40

S-14 : Nitric Oxide: A Treatment for Biofilms Lacking C-Di-Gmp

Pathways?

Raymond Allan (United Kingdom)

13:40-13:55 S-15 : Repurposing Auranofin and Ebselen: Increasing the

Antifungal Arsenal

Gina Wall (USA)

13:55-14:10

S-16 : O2 Affects the Activity of Amikacin on Mycobacterium

abscessus Biofilm

Mette Kolpen (Denmark)

14:10-14:25

S-17 : Non-Thermal Plasma Exposure Increases Biofilm Antibiotic

Sensitivity

Brendan Gilmore (United Kingdom)

14:25-14:50

S-18 : New Anti-Biofilm Therapeutics from Understanding

Biofilm Development

Jeremy Webb (United Kingdom)


Notes

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................



Session 4

Blue Room

Environmental biofilms, Consequences for Health and Disease

Chairs: Mette Burmølle (Denmark), Birthe Kjellerup (USA)

13:00-13:25

S-19 : Synergistic Interactions in Multispecies Biofilms in Nature,

Households and Industry

Mette Burmølle (Denmark)

13:25-13:40

S-20 : Novel Strategy for the Treatment of Microcystins from M.

aeruginosa

Gisella Lamas Samanamud (USA)

13:40-13:55

S-21 : Distribution of the Human Skin Microbiota

Lene Bay (Denmark)

13:55-14:10

S-22 : Hospital Surface Biofilms Promote Antibiotic Resistant

Organisms

Karen Vickery (Australia)

14:10-14:25

S-23 : Hospital and Urban Wastewater Biofilms Compared to

River Biofilms Grown In Situ and in a Lab Model

Elena Buelow (France)

14:25-14:50

S-24 : Impact of Biofilm Based Bioremediation Technologies on

Public Health

Birthe Kjellerup (USA)


Notes

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................



Session 5

Red Room

Biofilms Systems Biology

Chair: Thomas Bjarnsholt

15:15-15:40

S-25 : Multi-omics Approach to Study Oral Biofilms

Bart Keijser (The Netherlands)

15:40-16:05

S-26 : Modelling Biofilm Mechanics

Cristian Picioreanu (The Netherlands)

16:05-16:25

Forum Discussion:

Moderated by: Bart Keijser (Nl) / Christian Picioreanu (Nl) / Phil

Stewart (USA) / Thomas Bjarnsholt (Den) / Joost Teixeira de

Mattos (Nl)

Notes

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................



Session 6

Blue Room

Biofilm Matrix

Chair: Michel Hoogenkamp (The Netherlands)

15:15-15:30

S-27 : Effect of Extracellular Polysaccharides Matrix on Bacterial

Population

Antônio Pedro Ricomini Filho (Brazil)

15:30-15:45

S-28 : Development of an In Vitro Biofilm Model Using

Microfluidics

Hervé Straub (Switzerland)

15:45-16:00

S-29 : Pseudomonas aeruginosa Lectins: Biological Roles and

Binding Partners in BiofilmsDaniel Passos da Silva (USA)

16:00-16:15

S-30 : Homogenous Biofilm Microclusters for Multiplex Array

Analyses

Julia Bruchmann (Germany)

16:25-17:05 Poster Session A

Lobby and Foyer 1st

Floor

17:05-17:45 Poster Session B (with Complimentary Drinks)

Lobby and Foyer 1st

Floor

Notes

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................


Thursday September 21 – Venue: de Meervaart Theatre

8:30 – Registration

9:00-9:45

Red Room

Key Note Lecture:

K-03 : Engineering Multi-Species Biofilms and Controlling Them

in Infections

Thomas Wood, Penn State College of Engineering,

University Park, United States of America


Session 7

Red Room

Host Responses to Biofilms and Potential Vaccination Targets

Chairs: Mark Shirtliff (USA), Paul Cos (Belgium)

10:15-10:40

S-31 : The Immune Response to Biofilms: Opportunities for

Treatment, Prevention, and Diagnosis

Mark Shirtliff (USA)

10:40-10:55

S-32 : Recognition of Persister Cells by the Host

Claudia Marques (USA)

10:55-11:10

S-33 : Critical Parameters for Neutrophil Control of Nascent

Biofilm

Phil Stewart (USA)

11:10-11:25

S-34 : P. aeruginosa Variant Biofilms are Inflammatory and

Persist In Vivo

Matthew Pestrak (USA)

11:25-11:40

S-35 : Polyvalent Biofilm-Directed Immunization Kills

Staphylococcus aureus

Janette Harro (USA)

11:40-12:05

S-36 : Research on Biofilms and Oxidative Stress: Setting

Standards!

Paul Cos (Belgium)


Session 8

Blue Room

Evolution and Adaptation in Biofilms

Chairs: Ákos Kovacs (Denmark), Sara Mitri, (Switzerland)

10:15-10:40

S-37 : Collapse of Genetic Division of Labor and Evolution of

Autonomy in Pellicle Biofilms

Ákos Kovacs (Denmark)

10:40-10:55

S-38 : Dynamic Biofilm Architecture Confers Collective Viral

Protection

Carey Nadell (USA)

10:55-11:10

S-39 : Evolution of Antimicrobial Resistance in Polymicrobial

Biofilms

Conor Frapwell (United Kingdom)

11:10-11:25

S-40 : Stabilisation of Interspecific Interactions by Biofilm

Formation

Henriette Røder (Denmark)

11:25-11:40

S-41 : A Division of Labor During Pseudomonas aeruginosa

Surface Sensing

Catherine Armbruster (USA)

11:40-12:05

S-42 : Spatial Organisation Affects Co-evolution in Small

Microbial Communities

Sara Mitri (Switzerland )


Notes

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................



Session 9

Red Room

Mixed Species Biofilms

Chairs: Gordon Ramage (UK), Ilse Jacobsen (Germany)

13:00-13:25

S-43 : Unravelling Metabolic Circuitry Within Inter-Kingdom

Biofilm Interactions

Gordon Ramage (United Kingdom)

13:25-13:40

S-44 : Impact of a Methylobacterium Species in Drinking Water

Biofilms

Erifyli Tsagkari (United Kingdom)

13:40-13:55

S-45 : Synergism in Biofilms of C. albicans Mutant Strains and

Streptococci

Daniel Montelongo-Jauregui (USA)

13:55-14:10

S-46 : Unravelling the Biofilm Core Microbiome in Cooling Tower

Systems

Luciana Di Gregorio (Italy)

14:10-14:25

S-47 : Cf Multispecies Dynamics: Role of Oxygen Milieu and

Antibiotic Therapy

Susana Lopes (Portugal)

14:25-14:50

S-48 : Interactions Between Candida albicans and Intestinal

Bacteria: Foes or Brothers in Arms?

Ilse Jacobsen (Germany)

Notes

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................



Session 10

Blue Room

Microenvironment and Physiology of Infectious Biofilms

Chairs: Peter Østrup Jensen (Denmark), Joost Teixeira de Mattos

(The Netherlands)

13:00-13:25

S-49 : Effects of the Host Response on the Microenvironment

and Physiology of Infectious Biofilm

Peter Østrup Jensen (Denmark)

13:25-13:40

S-50 : Transcriptome Profiling of Dispersed Cells from P.

aeruginosa Biofilms

Rohit Ruhal (Belgium)

13:40-13:55

S-51 : Biofilms in Lumbar Disk Herniation - a Prospective Proof of

Concept

Blaine Fritz (Denmark)

13:55-14:10

S-52 : An Artificial Sebum Model to Explore Propionibacterium

acnes Biofilm

Karl-Jan Spittaels (Belgium)

14:10-14:25

S-53 : How Can In Vitro Models Best Reflect In Vivo

Staphylococcus Biofilms?

Rikke Louise Meyer (Denmark)

14:25-14:40

S-54 : How Material Stiffness Affects E. coli Attachment: A Role

of Motb

Dacheng Ren (USA)


15:20-16:00 Poster Session C

Lobby and Foyer 1st

Floor

16:00-16:40 Poster Session D (with Complimentary Drinks)

Lobby and Foyer 1st

Floor


Friday September 22 – Venue: de Meervaart Theatre

Session 11

Red Room

Mechanics and physics in and of biofilms

Chairs: Prashant Sharma (The Netherlands), Paul Stoodley (USA)

9:00 – 09:25

S-55 : Viscoelasticity of Microbial Biofilms

Prashant Sharma (The Netherlands)

09:25 – 09:40

S-56 : Viscoelastisity Determines Biofilm Recalcitrance to

Antimicrobials

Rene Rozenbaum (The Netherlands)

09:40 – 09:55

S-57 : P. aeruginosa Biofilms Adapt Their Rheological Properties

to Infection

Erin Gloag (USA)

09:55 – 10:10

S-58 : Multiphoton Microscopy for Measuring Drug Delivery to

Biofilms

Hanna Thomsen (Sweden)

10:10 – 10:25

S-59 : Impact of Material Stiffness on Bacterial Adhesion

Jules Valentin (Switzerland)

10:25 – 10:50

S-60 : Biofilm Mechanics and Implications for Control in

Orthopaedic Implant Infections

Paul Stoodley (USA)



Session 12

Blue Room

Social interactions in mixed species biofilms

Chairs: Aurélie Deveau (France), Nicholas Jakubovics (UK)

9:00 – 09:25

S-61 : Ménage à Trois (and more) : Bacterial Biofilm Formation

on Soil Fungal Hyphae and Tree Roots

Aurélie Deveau (France)

09:25 – 09:40

S-62 : C. albicans Alters the Bacterial Microbiome of In Vitro Oral

Biofilms

Bastiaan Krom (The Netherlands)

09:40 – 09:55

S-63 : Porphyromonas gingivalis Uses Citrullination in Mixed

Species Biofilms

Justyna Karkowska-Kuleta (Poland)

09:55 – 10:10

S-64 : Competition Between Cells and Aggregates in Bacterial

Biofilms

Pahala Gedara Jayathilake (United Kingdom)

10:10 – 10:25

S-65 : Interaction Between P. aeruginosa and S. epidermidis

Clinical Isolates

An Hotterbeekx (Belgium)

10:25 – 10:50

S-66 : Dental Plaque: Social Networking on a Microbial Scale

Nicholas Jakubovics (United Kingdom)

10:50 – 11:20 Coffee Break

Notes

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................



Session 13

Red Room

Remaining Fundamental Questions and Standardization in

Biofilm Research

11:20 – 11:50

S-67 : Measuring Antimicrobial Efficacy Against Biofilms

Phil Stewart (USA)

11:50 – 12:20

S-68 : “That Which we Call a Rose, by any Other Name Would

Smell as Sweet” – But is a Lack of Standardization and

Uniform Terminology Hampering Progress in Biofilm

Research?

Tom Coenye (Belgium)

12:20 – 12:40

Forum Discussion:

Moderated by: Phil Stewart (USA) / Tom Coenye (Belgium)/

Bastiaan Krom (The Netherlands)

12:40 – 13:00 Poster awards – Closing Ceremony

13:00 – 14:00 Closing Lunch

Do not forget to remove your poster

Notes

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................


General Information

Opening of the meeting on Tuesday September 19 will be at the Academic

Centre for Dentistry Amsterdam,

Gustav Mahlerlaan 3004, Amsterdam

The Congress Venue is Theater De Meervaart,

Meer en vaart 300, Amsterdam

The Red Room is located on the

ground Floor.

The Blue Room is located on the

first Floor

Coffee- and Lunch breaks and

Poster Sessions are in the foyer on

the ground floor (posters 1-81)

and 1st floor (posters 82-151).


Transportation.

Public Transport in Amsterdam is easy and convenient. You can use 9292ov.nl to

figure out your travel to and from your hotel. Here we would like to limit the

information on how to travel to downtown Amsterdam (take Tram 1 or 17) or to

Schiphol (line 69). On the website of Eurobiofilms2017 detailed information on

transport is available with links to sites with additional information.

Internet Access

At ACTA the WiFi connection can be established through Eduroam.

Theater De Meervaart offers free WiFi access. It is a public environment

so be careful when you use WiFi.

Language

The official language of Eurobiofilms2017 is English. No translations will be provided.

Name badge

Entrance to sessions will be limited to badge holders only. If your badge is lost

contact the registration desk. A fee of €7 will be charged for each new badge.

Staff from the exhibition does not have access to the oral sessions.

Insurance

You are requested to arrange your own health and travel insurance. The Congress

Organizer and the Congress Venue are not responsible for any injuries or damages

that may occur during the congress.

Luggage storage

On Friday September 22 there are possibilities to store your luggage at the venue.

However, the room is not under surveillance and storing your luggage is at your own

risk.


Oral Presentations.

Audio-visual equipment

• The auditoria at the Congress venue will be equipped with PC’s which support the

use of all recent versions of Microsoft PowerPoint.

• Please bring your presentation on a USB stick. Make sure to have a backup

somewhere.

• All presenters are strongly recommended to use the PCs provided by the

organisation and should upload their presentation in the break before their session

the latest, and preferably earlier.

• If you are bringing your own laptop, please check that you are able to hook up your

laptop to the video projector (through a VGA port) at least in the break before your

session.

• We recommend you to bring your own electrical adapter as well.

• There will be no Preview Room available.

Presentation

• Speakers are requested to present themselves to the chairperson in the lecture

room, 10 minutes prior to the beginning of their session.

• Each presentation is scheduled to last for 15 minutes, which means approx. 10

minutes for the actual presentation, leaving 5 minutes for questions.

• Please respect the time limits.

• The moderator is responsible for the time keeping and will interrupt if a

presentation extends beyond the allocated time.

• Be aware that social media will follow presentations. Taking photographs of the

content of presentations will be prohibited.


Poster Presentations

All posters should be mounted on Wednesday, 20th of September by 09:00 and

will remain mounted for the duration of the Congress. Materials for mounting your

poster are made available.

All posters must be removed after the final session on Friday, September 22nd

2017. Posters that will not be removed at the end of the Congress will be removed

by the organizers, who cannot be held responsible for any damages.

Each abstract selected for a poster presentation has been assigned a poster board

code. This code starts with a letter (A-D) indicating the Poster Session followed by a

number.

All poster boards are consecutively numbered and the letters indicate the poster

session.

You are expected to be at your assigned space and time to present your work.

Poster

Session

Day

Time

A Wednesday September 20 16:25 – 17:05

B Wednesday September 20 17:05 – 17:45

C Thursday September 21 15:20 – 16:00

D Thursday September 21 16:00 – 16:40

In order to allow for more viewing space around the posters, posters within the

same subject are divided over multiple sessions. At the same time all posters

within the same subject are still grouped together.


Poster Line Up

Poster Session Day Time

A Wednesday September 20 16:25 – 17:05

B Wednesday September 20 17:05 – 17:45

C Thursday September 21 15:20 – 16:00

D Thursday September 21 16:00 – 16:40

Social interactions in mixed species biofilms

1 A Marine Bacteria Co-Culture: Production Of Antibiofilm

Compounds

Anelise Baptista Da Silva (Brazil)

2 B Metagenome Of Polymicrobial Biofilms Harbouring Listeria

monocytogenes

Marta Cabo (Spain)

3 C L. crispatus Protects HeLa Cells Against G. vaginalis Cytotoxicity

Nuno Cerca (Portugal)

4 D S. aureus Modulates P. aeruginosa Small Colony Variants

Formation

Susana Patrícia Lopes (Portugal)

5 A Elucidating Priority Effects In Multispecies Biofilm Assembly

Nanna Mee Coops Olsen (Denmark)

Microenvironment and physiology of infectious biofilms

6 B Bacterial Rhamno-Polysaccharides Interact With Hydrophobic

Compounds

Paola Cescutti (Italy)

7 C Identifying Oxygen Responsive Biofilm Regulators In Upec

Allison Eberly (United States)

8 D Adenoids, Friends Or Foes?

Maria Luisa Jordao (Portugal)


9 A New Method Enables Measuring Distance-To-Surface

Antimicrobial Effect

Ales Lapanje (Slovenia)

10 B Can Physical Strength Of Biofilm Matrix Inhibit Bacterial Division?

Ales Lapanje (Slovenia)

11 C Biofilm Formation By Cutibacterium acnes

Sophie Pécastaings (France)

Notes

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................


Mixed species (including bacterial-fungal) biofilms

13 A Candida albicans And Propionibacterium acnes: Partners In

Biofilms?

Clément Bernard (France)

14 B Multispecies Dry Biofilm Model: Detergent Efficacy Testing Tool

Durdana Chowdhury (Australia)

15 C Seasonal Diversity Of Phototrophic Biofilms In Cooling Towers.

Francesca Di Pippo (Italy)

16 D Candida albicans Protects Anaerobial Bacteria In Mixed Species

Biofilm.

Dominika Ostrowska (Poland)

17 A Mixed Species In An Alginate Bead Model

Majken Sønderholm (Denmark)

18 B Controlling Negative Flora In Dairy Industry With Positive

Biofilms?

Sophie Pécastaings (France)

19 C Modelling Chronic Wound Infection In Vitro And Immunological

Response

Craig Williams (United Kingdom)

Biofilm based medical device related infections

21 B Introducing Mycobacterium chimaera Biofilms: A First Glimpse

Into The World Of M. chimaera Biofilms On Medical Device

Surfaces

Jayaleka Amarasinghe (USA)

22 C Antibiofilm Activities Of Marine Streptomyces Against

Staphylococci

Srikkanth Balasubramanian (Germany)

23 D The Influence Of Human Plasma On Staphylococcus epidermidis

Virulence

Ângela França (Portugal)

24 A Effect Of Go On Biofilm-Growing E. coli And K. pneumoniae

Strains


Claudia Vuotto (Italy)

25 B Biofilm And Breast Implant Associated Anaplastic Large Cell

Lymphoma


26 C Antibiotic-Loaded Beads To Prevent Biofilm In Prosthetic

Infection

Paul Stoodley (United Kingdom)

27 D Biofilm Matrix-Degrading Enzymes Detach Staphylococci From Pig

Skin

Jeffrey B. Kaplan (United States)

28 A Biofilm Formation On Various Surfaces Of Cochlear Implants

Lisa Kirchhoff (Germany)

29 B Bone Environment Influences Staphylococcus aureus Biofilm

Formation

Fany Reffuveille (France)

30 C Pathology Of Candida’s Biofilms Related To Catheters

Seddiki Sidi Mohammed Lahbib (Algeria)

31 D The Effect Of Organic Conditioning Films On Medical Devices.

Kathryn A Whitehead (United Kingdom)

32 A Modify And Characterise Platelet Bags To Prevent Biofilm Growth

Joels Wilson-Nieuwenhuis (United Kingdom)

33 B Bacterial eDNA Production And Outcome Of Prosthetic Joint

Infections

Beata Zatorska (Austria)

34 C Modeling And Disruption Of Peri-Implantitis Microcosm Biofilms

Vanessa Sousa (United Kingdom)

Miscellaneous

36 A Methods For Amyloid Detection In Staphylococcus aureus

Biofilms

Mara Baldry (Denmark)

37 B Progesterone Modulates Candida albicans Biofilm Formation /

Expression

Bruna Fernandes Gonçalves (Portugal)


38 C Validation Of Chronic Lung Infection By Pa For Novel Mvfr

Inhibitors

Vanesa Garrido (Italy)

39 D Exopolysaccharides Produced By Burkholderia cenocepacia In

Biofilms

Paola Cescutti (Italy)

40 A Antimicrobial And Antibiofilm Properties Of New Isatin

Derivatives

Isabelle Lanneluc (France)

41 B Role Of Substratum Surface Energy & Treatments On Microbial

Adherence

Jonathan R Palmer (United Kingdom)

42 C Pa2440 And Pa2441 Affect Biofilm Formation By Pseudomonas

aeruginosa

Morten Rybtke (Denmark)

43 D Evaluation Of Biofilms Fungal Cells Viability Using Iron Seeds

Seddiki Sidi Mohammed Lahbib (Algeria)

44 A Itraq-Based Quantitative Proteomics Of Strong And Weak Biofilm

Formers Of Enterococcus faecalis Reveals Novel Regulators Of

Biofilm Formation

Tanujaa Suriyanarayanan (India)

45 B Accredited Biofilm Test Methods: What It Means For Wound Care

Hannah Thomas (United Kingdom)

46 C Essential Oils Against Staphylococcus spp. And P. aeruginosa

Biofilm

Rosanna Papa (Italy)

47 D Hydrophobin Coated Surfaces Prevent S. epidermidis Biofilm

Formation

Gianluca Vrenna (Italy)

Environmental biofilms, consequences for health and disease

48 B Dry Hospital Surfaces: The Difficulty In Killing Pathogens In

Biofilms



49 C Biofilms In Ornamental Waters: A Risk Assessment Study

Luisa Jordao (Portugal)

50 D Methanogenic Archaea- The Impact On Material, Environment

And Health

Andrea Koerdt (Germany)

51 A Borrelia Ssp. Are Able To Create Biofilm-Like Aggregates In Vitro

Kasper Nørskov Kragh (Denmark)

52 B The Antibiofilm Power Of Marine Bacteria

Isabelle Lanneluc (France)

53 C Sponge Inspired Two Derivatives To Prevent And To Disrupt

Biofilms

Tiffany Le Norcy (France)

54 D Biofilm Lifestyle Of Coral-Associated Bacteria From Andaman Sea

Rinchen Tshering Lepcha (India)

55 A Antifouling Properties Of Novel Electrospun Nanofibre

Membranes

Premysl Mikula (Czechia)

56 B Modelling Mono-Species Biofilms For Environmental Efficacy

Testing

Fergus Watson (United Kingdom)

57 C Dgch Is A House-Keeping Dgc In Pseudomonas aeruginosa

Qing Wei (China)

58 D In Vitro Water Biofilm Growth In Presence Of Disinfection Agents

Charifa Zemouri (Netherlands)

Oral Biofilms in health and disease

60 A Halitosis Biofilm: A Study Combining Culture And Cloning

Technique

Ali Al-Ahmad (Germany)

61 B Investigating Oral Bacterial Species Metabolites As Toxins In

Disease

Niall Anthony Hickey (United Kingdom)

62 C Extracellular DNA Production In Streptococcus gordonii Biofilms

Catherine Lawler (United Kingdom)


63 D An Oral Biofilm Model On Dentine Cones To Test Disinfection

Strategies

Merete Markvart (Denmark)

64 A Effect Sgc On Gene Regulation In S. gordonii Following

Coaggregation

Nick Jacubovics (United Kingdom)

65 B Raffinose Stimulates Biofilm Formation Of Streptococcus mutans

Ryo Nagasawa (Japan)

66 C Mechanisms Of Antimicrobial Tolerance In Streptococcus mutans

Biofilms

Martin Nilsson (Denmark)

68 A Volatiles Produced By Candida spp. On Denture Materials

James Redfern (United Kingdom)

69 B Evaluating Chlorhexidine Efficacy In Multi-Species Oral Biofilm

Models

Tracy Shaw (United Kingdom)

70 C Scfas-Stimulated Attachment And Biofilm Formation Of

Actinomyces oris

Itaru Suzuki (Japan)

71 D Biofilm Model Systems For Root Canal Disinfection: A Literature

Review

Rosalie Charlotte Swimberghe (Belgium)

Evolution and adaptation in biofilms

72 A Phenotypic Diversity Within Environmental P. aeruginosa

Populations

Stephanie Crone (Denmark)

73 B Evolution Of RpoE During S. pneumoniae Biofilm Development

Robert Hull (United Kingdom)

74 C Evolution Of Phenotypic Heterogeneity In Bacillus subtilis

Biofilms

Marivic Carnacete Martin (Germany)


75 D Genomic Analysis Of P. aeruginosa Biofilm In A Model Water

System

Benjamin McDonagh (United Kingdom)

76 A Surface Communities Are Altered By An Artificial Biofilm

Tomaz Rijavec (Slovenia)

Host responses to biofilms and potential vaccination targets

77 B P. aeruginosa In Vivo Biofilm Contains Host Components

Maria Alhede (Denmark)

78 C Biofilm-Producing Staphylococcus aureus In Severe Atopic

Dermatitis

Enea Gino Di Domenico (Italy)

79 D A Possible Role For Paraoxonase In Urinary Tract Infection

John E. Lafleur (United States)

80 A K. pneumoniae Polysaccharides: Interaction With Antimicrobial

Peptides

Roberto Rizzo (Italy)

81 B Role Of C-Type Lectins In Pseudomonas aeruginosa Biofilm

Recognition

Sonali Singh (United Kingdom)

Notes

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................


Mechanics and physics in and of biofilms

82 A Identification Of The Mechanical Properties Using Microbeads

Héloïse Boudarel (France)

83 B Real-Time Changes Of Cell Surface Nanotopography In Biofilm

Genesis

Rym Boudjemaa (France)

84 C Cell Wall Weakening By Antibiotics In Adhering Bacteria

Vera Carniello (Netherlands)

85 D Integrating Metabolomics And Transcriptomics For Biofilm

Research

Christopher Delaney (United Kingdom)

87 B Host Proteins Determine MRSA Biofilm Structure And Integrity

Cindy Dreier (Denmark)

88 C Surface Topology Affects Wetting Behaviour Of B. subtilis Biofilms

Carolina Falcón García (Germany)

89 D Role Of Biofilm Mechanics On Internal And Global Biofilm

Architecture

Raimo Hartmann (Germany)

90 A The Effects Of The Substrate’s Surface Topography On Biofilm

Formation

Shun Miyazaki (Japan)

91 B Novel Visualisation Method Shows Biofilm Structure Dictates

Disruption

Xenos Petridis (Netherlands)

92 C Relating Composition, Structure And Strength Of Artificial

Biofilms

Natascha Monique Pfaff (Netherlands)

93 D A Front Propagation Model For Phototropic Microbial Biofilms

Dynamics

Andrea Trucchia (Spain)

94 A Light Spatio-Temporal Control Of Curli In Multifunctional Biofilms

Marco Valentim Becker (Brazil)

95 B Shear-Induced Transmission Of Lubricious Staphylococcal Biofilms

Henny C van der Mei (Netherlands)


96 C Biofilms On Membrane Filters: Improvements Towards Axenic

Conditions

Rik de Vries (Netherlands)

97 D Modelling Nanoindentation Of Biofilms Grown On The Microbead

Yuqing Xia (United Kingdom)

98 A Prediction Of Biofilm Streamer Formation With Ibm

Yuqing Xia (United Kingdom)

Notes

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................


Treatment of biofilm infections and development of biofilm resistance

99 A Activity Of A Nitric Oxide Generating Dressing Against Wound

Biofilms.

Robert Allaker (United Kingdom)

100 B A New Vegetal-Nanotechnological Strategy On Candida albicans

Biofilms

Tais Maria Bauab (Brazil)

101 C Treatment Of Pseudomonas aeruginosa Biofilm In Human Mucus

Environment

Sabine Wronski (Germany)

102 D Astronium Urundeuva Plant And Its Effect On Candida Biofilms

Bruna Bonifacio (Brazil)

103 A Recovery Of Bacterial Biofilms With Susceptible Cells And

Persisters

Gabriel Carvalho (France)

104 B Natural Honey To Fight Candida Infections

Maria Elisa Costa Rodrigues (Portugal)

105 C Biogenic Selenium Nanoparticles As An Alternative To Treat

Biofilms

Eleonora Cremonini (Italy)

106 D Selenium Nanoparticles And Antibiotics Synergy Against Biofilms

Eleonora Cremonini (Italy)

107 A Activity Of Antibiotics Against P. aeruginosa And S. aureus

Biofilms

Yvan Diaz Iglesias (Belgium)

108 B Synergistic Effect Of Cold Plasma And Lysostaphine On S. aureus

Biofilm

Parastoo Ehsani (Islamic Republic of Iran)

109 C Studying Bacterial And Fungal Biofilm Formation In Real-Time

Mª Desamparados Ferrer García (Spain)

110 D Biodegradable And Antibacterial Materials To Prevent Biofilm

Formation

Claudia Fessele (Switzerland)


111 A Glycoside Hydrolases Degrade Polymicrobial Biofilms In Chronic

Wounds

Derek Fleming (United States)

112 B Acinetobacter Baumannii Biofilms Susceptibility To Cold Plasma

Padrig Benjamin Flynn (United Kingdom)

113 C Raspberry Woods And Leaves: Sources Of New Anti-Biofilm

Compounds?

Clément Bernard (France)

114 D Management Of Dairy Industry Contaminations: Use Of Phenolic

Extracts

Fernanda Gomes (Portugal)

115 A Anti-Persister Activity Of Membrane-Active Antimicrobial

Peptides

Lucia Grassi (Italy)

116 B Structural Insight Into Blocking The Biofilm Formation Of Bacteria

Shuaiqi Guo (Netherlands)

117 C Evaluation Of Antimicrobial Wound Solutions Against Microbial

Biofilms


Notes

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................


Treatment of biofilm infections and development of biofilm resistance -

continued

118 D Antimicrobial Activity Of Metals & Graphene Against Bacteria

Nathalie Karaky (United Kingdom)

119 A Candida auris Biofilms: Implications For Antimicrobial Therapy

Ryan Kean (United Kingdom)

120 B Glutathione Disrupts Pseudomonas aeruginosa Biofilms

Theerthankar Das Ashish AshishKumar (Australia)

121 C Potential For Repurposing Bronidox And Bronopol As Anti-Biofilm

Agents

Victoria Lee (United Kingdom)

122 D Naturally Inspired Compounds As Quorum Sensing Inhibitors

Suvi Manner (Finland)

123 A Matrix Impact On Bacterial Biofilms Response To Cold Plasma

Treatments

Claire-Emmanuelle Marcato-Romain (France)

124 B A Fluorescent Microplate Assay For Burkholderia cenocepacia

Virulence

Ilkka Miettinen (Finland)

125 C Hyperbaric O2 Aids Tobramycin Effect On Pseudomonas

aeruginosa Biofilm

Signe Agnete Møller (Denmark)

126 D Antibiofilm Effect Of 1,10-Phenanthrolinium Bromide Against C.

albicans

Titik Nuryastuti (Indonesia)

127 A A Targeting Agent For Drug Delivery To Staphylococcus aureus

Biofilms

Pernille Ommen (Denmark)

128 B Anti-Biofilm Activity Of Pentadecanal And Its Synthetic

Derivatives

Ermenegilda Parrilli (Italy)

129 C Biofilms In A Wound Environment Respond Better To Topical

Gentamicin.

Bianca Louise Price (United Kingdom)


Notes

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................


130 D Core-Shell Silver Nanoparticles Enable Long-Term Antimicrobial

Effects

Qun Ren (Switzerland)

131 A Polar Marine Bacteria As Novel Source Of Anti-Biofilm Agents

Annarita Ricciardelli (Italy)

132 B Silver Nanoparticles As Topical Antibiofilm Approach

Katharina Richter (Australia)

133 C Mnn2 Gene Affects Drug Resistance In Candida glabrata

Biofilms

Celia Fortuna Rodrigues (Portugal)

134 D Portrait Of Gene Expression In C. glabrata With Stress Induced By

Drugs

Celia Fortuna Rodrigues (Portugal)

135 A A Novel Biaryl Amide Inhibitor Of Candida albicans Biofilm

Formation

Jesus Antonio Romo (United States)

136 B The Beat-AMR Consortium: Biofilm-Associated Antimicrobial

Resistance

Frank Schreiber (Germany)

137 C Anti-Biofilm Assays Platform Suited For Natural Products Libraries

Malena Skogman (Finland)

138 D Biofilm And Antibiotic Resistance In Beta-Haemolytic Streptococci

Dag Harald Skutlaberg (Norway)

139 A Nitric Oxide Donor Pro-Drugs Against Pseudomonas aeruginosa

Biofilms

Odel Soren (United Kingdom)

140 B Membrane Fatty Acid Composition Runs S. aureus Tolerance To

Daptomycin

Karine Steenkeste (France)

141 C Extreme Halophilic Microorganisms As A Source Of Antibiotic

Diversity

Thomas Philip Thompson (United Kingdom)

142 D Antimicrobial Efficacy Of Metals Against Pathogenic Bacteria.

Misha Vaidya (United Kingdom)


Treatment of biofilm infections and development of biofilm resistance -

continued

143 A Antiseptic-Resistant Oral Pathogens Are Cross-Resistant To

Antibiotics

Tim Verspecht (Belgium)

144 B Antibiofilm Activity Of Antarctic Bacterial Metabolites

Sharon Vieira dos Reis (Brazil)

146 A A New Indole Compound With Unique Activity Against Candida

Biofilms

Taissa Vila (United States)

147 B Biofilm Formation In Bacteria That Cause Urinary Tract Infection

Arkadii Vodianyk (Ukraine)

148 C Mechanism Of Trq Injection In Disrupting Biofilm Staphylococcus

aureus

Yi Wang (China)

149 D Antibiotic Tolerance Of Dispersed P. aeruginosa Cells

Jasper Wille (Belgium)

150 A The Design, Synthesis And Evaluation Of Prodrugs To Control

Biofilms

Danica Walsh (United States)

Notes

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................


Notes

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................

.....................................................................................................................................


Thank you for visiting Amsterdam.

Hope to meet you at EUROBIOFILMS 2019

September 3 -6, Glasgow, United Kingdom

Final Programme Eurobiofilms 2017 Fifth European Congress ... · September 19-22, Amsterdam, The...

Documents

Transcript of Final Programme Eurobiofilms 2017 Fifth European Congress ... · September 19-22, Amsterdam, The...